Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Benyi Li"'
Autor:
Jiang Zhao, Xing Luo, Chengfei Yang, Xiao Yang, Min Deng, Bishao Sun, Jingzhen Zhu, Zongming Dong, Yangcai Wang, Jia Li, Xingliang Yang, Benyi Li, Xiangwei Wang, Ji Zheng
Publikováno v:
Immunity & Ageing, Vol 21, Iss 1, Pp 1-17 (2024)
Abstract Background Research has suggested significant correlations among ageing, immune microenvironment, inflammation and tumours. However, the relationships among ageing, immune microenvironment, cystitis and bladder urothelial carcinoma (BLCA) in
Externí odkaz:
https://doaj.org/article/2c8fb7538eb24c928899ae7ef719f398
Autor:
Chenchen He, Linlin Ma, Jeff Hirst, Fei Li, Hao Wu, Wang Liu, Jiang Zhao, Feng Xu, Andrew K. Godwin, Xiangwei Wang, Benyi Li
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionAlternol is a natural compound isolated from the fermentation of a mutated fungus. We have demonstrated its potent anti-cancer effect via the accumulation of radical oxygen species (ROS) in prostate cancer cells in vitro and in vivo. In t
Externí odkaz:
https://doaj.org/article/bb74bb9f5b694e3db95c11a1ed625183
Autor:
Wang Liu, Chenchen He, Changlin Li, Shazhou Ye, Jiang Zhao, Cunle Zhu, Xiangwei Wang, Qi Ma, Benyi Li
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Alternol is a small molecular compound isolated from the fermentation of a mutant fungus obtained from Taxus brevifolia bark. Our previous studies showed that Alternol treatment induced reactive oxygen species (ROS)-dependent immunogenic
Externí odkaz:
https://doaj.org/article/babc2f0e41b3491593532361575b2ac5
Autor:
Ying Zhang, Wei Wei, Changying Li, Siyuan Yan, Shanshan Wang, Shudong Xiao, Chenchen He, Jing Li, Zhi Qi, Benyi Li, Kuo Yang, Changlin Li
Publikováno v:
Cell Death and Disease, Vol 13, Iss 12, Pp 1-11 (2022)
Abstract Although second-generation therapies like abiraterone (ABI) and enzalutamide (ENZ) benefit patients with castration-resistant prostate cancer (CRPC), drug resistance frequently occurs, eventually resulting in therapy failure. In this study,
Externí odkaz:
https://doaj.org/article/6ac3d9b24a9341f2900ef87f581a1cc8
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundHistone demethylase RIOX2 was cloned as a c-Myc downstream gene involved in cell proliferation and has been implicated as an oncogenic factor in multiple tumor types. Its expression profiles and correlation with disease progression in prost
Externí odkaz:
https://doaj.org/article/1b32f7be5b2b4f7aaa2b7a22d54ba3c8
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/6135d6805a704edf90bac99aa592fff0
Autor:
Jian Huang, Wang Liu, Shiqi Song, Jean C. Li, Kaimei Gan, Chunxiao Shen, Jeffrey Holzbeierlein, Benyi Li
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Reliable biomarkers are rare for renal cell carcinoma (RCC) treatment selection. We aimed to discover novel biomarkers for precision medicine. The iron-regulating hormone hepcidin (HAMP) was reportedly increased in RCC patient sera and ti
Externí odkaz:
https://doaj.org/article/c8aa4789f2e045e4a2aca2cf8c3b3ecb
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMembrane protein TMEM158 was initially reported as a Ras-induced gene during senescence and has been implicated as either an oncogenic factor or tumor suppressor, depending on tumor types. It is unknown if TMEM158 expression is altered in p
Externí odkaz:
https://doaj.org/article/a4506ca1207f48b39bb3234afac7837b
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/4a1143179cec4d61930b184b0dadab77
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Prostate cancer is a major health issue in western countries and is the second leading cause of cancer death in American men. Prostate cancer depends on the androgen receptor (AR), a transcriptional factor critical for prostate cancer growth and prog
Externí odkaz:
https://doaj.org/article/4eeede6136af4c88b5504c3447da3e03